Opendata, web and dolomites

ICA-100

A NOVEL NON-INVASIVE SOLUTION FOR CONTINUOUS BLOOD PRESSURE MONITORING

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ICA-100 project word cloud

Explore the words cloud of the ICA-100 project. It provides you a very rough idea of what is the project "ICA-100" about.

critical    intensive    validated    sphygmomanometers    undertaken    unstable    risks    patents    hypertensive    protected    hospital    obvious    operate    hitherto    granting    frequent    individuals    deployment    pressure    decades    healthy    performance    device    movements    continuous    line    hypo    hemodynamically    3b    financial    limitations    solutions    poses    follow    diastolic    massive    thoroughly    attempts    read    trl5    655m    strategy    regulatory    limited    care    patients    catheter    episodes    framework    completing    market    regarding    effect    certified    units    accurate    capability    commercialise    severe    systolic    tracking    ica    besides    periodic    none    mercury    gold    regarded    arterial    obtaining    recalibrations    positive    influence    icaria    complications    simplicity    tension    blood    technique    accuracy    purpose    volunteers    ing    invasive    plan    relative    monitoring    patient    serious    standard    monitor    international    hyper    marketing    despite    feasibility    poor    frame    solution    freedom    obstacles    icu   

Project "ICA-100" data sheet

The following table provides information about the project.

Coordinator
ICARIA MEDICAL S.L. 

Organization address
address: PZ PAU VILA, 1 PLANTA 2, PUERTA 2C EDIFICI PALAU DE MAR 2C
city: BARCELONA
postcode: 8039
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website https://www.icariamed.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-06-01   to  2019-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ICARIA MEDICAL S.L. ES (BARCELONA) coordinator 50˙000.00

Map

 Project objective

Blood pressure follow-up is essential in managing hemodynamically unstable patients at Intensive Care Units (ICU). Traditionally, mercury sphygmomanometers have been used for this purpose, and are regarded as the gold standard for Blood Pressure measurement. Despite the relative simplicity of the technique, sphygmomanometers have obvious limitations regarding accuracy and tracking capability, especially crucial for hospital patients. In the most critical patients the invasive arterial line catheter must be used, which however poses serious risks for severe complications. Over the past decades, several attempts have been undertaken to develop an effective, accurate and reliable solutions to continuously monitor blood pressure in a non-invasive way. Hitherto, none of the solutions under development have achieved a massive market deployment. Major obstacles for the implementation of state-of-the-art solutions are related to their limited performance, resulting in poor accuracy in hypo/hyper tension episodes, influence of patient movements on the system response, and need for periodic and frequent recalibrations. ICARIA has developed a solution for blood pressure monitoring (ICA-100) based on a novel operating principle that allows obtaining an accurate diastolic and systolic Blood Pressure read-out. The ICA-100 has already been validated in healthy volunteers (TRL5). The technology is protected by two international patents, granting ICARIA freedom-to-operate. In the frame of this Phase 1 Project we aim to further develop our marketing strategy and financial plan. Besides, we aim to assess thoroughly the relevant regulatory and legal framework for the Project. After completing this feasibility study, we plan to develop and commercialise a certified device for Continuous Non-Invasive Blood Pressure monitoring. Having a positive impact in 655m hospital patients and a potential favourable effect on 1.3b hypertensive individuals, from which only 1 in 5 is under control.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ICA-100" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ICA-100" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More